SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Pentixapharm Secures US Ethics Approval for PANDA Phase 3 Trial

Pentixapharm secured US ethics approval for its PANDA Phase 3 trial.

Related stories